Despite mixed results for its…
Despite mixed results for its experimental schizophrenia treatment last month, [...]
Despite mixed results for its experimental schizophrenia treatment last month, [...]
Just weeks after Legend Biotech announced the departure of its [...]
PDS Biotechnology has called a halt to its phase 3 [...]
PTC Therapeutics has struck a deal to buy Sangamo Therapeutics’ [...]
Taiho Pharmaceutical and Cullinan Therapeutics have celebrated a second phase [...]
As the FDA mulls whether to approve Takeda and Protagonist [...]
Three years after Robert Hoffman sold XinThera to Gilead, the [...]
Aardvark Therapeutics has confirmed it is walking away from recently [...]
Definium Therapeutics’ LSD formula has gone two for two in [...]
Amgen is expanding its footprint in India with an R&D [...]